XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Collaborations - Summary of Company's Accompanying Consolidated Financial Statements Attributable to Transactions Arising From Collaboration Arrangements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Incyte          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Revenue recognized in the period $ 4,371 $ 4,045 $ 12,912 $ 12,677  
Incyte | Accounts Receivable          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Billings     10,779    
Cash receipts     (9,779)    
Balance at September 30, 2023 1,000   1,000    
Incyte | Unbilled Receivables          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023     1,987    
Accrued receivables     10,152    
Billings     (10,779)    
Adjustments     44    
Balance at September 30, 2023 1,404   1,404    
Incyte | Deferred Revenue          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023 39,079   39,079   $ 52,059
Foreign exchange     (68)    
Revenue recognized in the period     (12,912)    
Balance at September 30, 2023 39,079   39,079   52,059
Less: current portion (16,882)   (16,882)    
Non-current balance at September 30, 2023 22,197   22,197    
Lilly          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Revenue recognized in the period 789 (551) 8,270 7,634  
Lilly | Accounts Receivable          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Billings     3,497    
Cash receipts     (3,497)    
Lilly | Unbilled Receivables          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023     808    
Accrued receivables     3,541    
Billings     (3,497)    
Adjustments     (7)    
Balance at September 30, 2023 845   845    
Lilly | Deferred Revenue          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023 7,914   7,914   16,130
Foreign exchange     54    
Revenue recognized in the period     (8,270)    
Balance at September 30, 2023 7,914   7,914   16,130
Less: current portion (6,137)   (6,137)    
Non-current balance at September 30, 2023 1,777   1,777    
Other          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Revenue recognized in the period 0 0 0 222  
Other | Accounts Receivable          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023     1,068    
Billings     68    
Cash receipts     (1,142)    
Foreign exchange     6    
Other | Unbilled Receivables          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023     189    
Foreign exchange     (4)    
Balance at September 30, 2023 185   185    
Collaboration Agreement          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Revenue recognized in the period 5,160 $ 3,494 21,182 $ 20,533  
Collaboration Agreement | Accounts Receivable          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023     1,068    
Billings     14,344    
Cash receipts     (14,418)    
Foreign exchange     6    
Balance at September 30, 2023 1,000   1,000    
Collaboration Agreement | Unbilled Receivables          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023     2,984    
Accrued receivables     13,693    
Billings     (14,276)    
Adjustments     37    
Foreign exchange     (4)    
Balance at September 30, 2023 2,434   2,434    
Collaboration Agreement | Deferred Revenue          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Balance at January 1, 2023 46,993   46,993   68,189
Foreign exchange     (14)    
Revenue recognized in the period     (21,182)    
Balance at September 30, 2023 46,993   46,993   $ 68,189
Less: current portion (23,019)   (23,019)    
Non-current balance at September 30, 2023 $ 23,974   $ 23,974